Susan E. Draheim
Eli Lilly (United States)(US)
Publications by Year
Research Areas
Synthesis and biological activity, Protein Kinase Regulation and GTPase Signaling, Antibiotic Resistance in Bacteria, Carbohydrate Chemistry and Synthesis, Multicomponent Synthesis of Heterocycles
Most-Cited Works
- → Structure-based design of the first potent and selective inhibitor of human non-pancreatic secretory phospholipase A2(1995)214 cited
- → Indole Inhibitors of Human Nonpancreatic Secretory Phospholipase A2. 3. Indole-3-glyoxamides(1996)91 cited
- → Pharmacology of LY315920/S-5920, [[3-(Aminooxoacetyl)-2-ethyl-1-(phenylmethyl)-1 H-indol-4-yl]oxy]acetate, a Potent and Selective Secretory Phospholipase A2Inhibitor: A New Class of Anti-Inflammatory Drugs, SPI(1999)88 cited
- → Indole Inhibitors of Human Nonpancreatic Secretory Phospholipase A2. 1. Indole-3-acetamides(1996)70 cited
- → Structure-activity relationship within a series of pyrazolidinone antibacterial agents. 2. Effect of side-chain modification on in vitro activity and pharmacokinetic parameters(1993)70 cited
- → Indole Inhibitors of Human Nonpancreatic Secretory Phospholipase A2. 2. Indole-3-acetamides with Additional Functionality(1996)48 cited
- → Discovery and structure-activity relationship of a series of 1-carba-1-dethiacephems exhibiting activity against methicillin-resistant Staphylococcus aureus(1993)41 cited
- → [3.3.0] Pyrazolodinones: An efficient synthesis of a new class of synthetic antibacterial agents.(1990)41 cited
- → Orally absorbable cephalosporin antibiotics. 2. Structure-activity studies of bicyclic glycine derivatives of 7-aminodeacetoxycephalosporanic acid(1985)38 cited
- → Orally absorbable cephalosporin antibiotics. 1. Structure-activity relationships of benzothienyl- and naphthylglycine derivatives of 7-aminodeacetoxycephalosporanic acid(1985)37 cited